Concepedia

Ute Manning

UM

9

Publications

454

Citations

9

H-Index

1995

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Ute Manning is an author at Novartis (Switzerland) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1995–2005

9

Publications

9

Pyrazoloheteroaryls: Novel p38α MAP kinase inhibiting scaffolds with oral activity

Láśzló Révész, Ernst Blum, Franco E. Di Padova et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 77 citations · Full text

, , +5

Rapid Identification of Phosphopeptide Ligands for SH2 Domains

Kurt Müller, Frank O. Gombert, Ute Manning et al. · Journal of Biological Chemistry · 1996 · 67 citations · Full text

Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis

Láśzló Révész, Ernst Blum, Franco E. Di Padova et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 60 citations · Full text

, , +11

SAR of 2,6-diamino-3,5-difluoropyridinyl substituted heterocycles as novel p38MAP kinase inhibitors

Láśzló Révész, Franco E. Di Padova, Thomas Buhl et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 56 citations · Full text

, , +5

SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors

Láśzló Révész, Franco E. Di Padova, Thomas Buhl et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 52 citations · Full text

, , +7

Rows per page

1–5 of 9